• Product NamePerindopril erbumine
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityPERINDOPRIL ERBUMINE is an angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.
• Target NameMRP inhibitor; RAAS inhibitor
• CAS No. 107133-36-8
• Calculated MW 441.61
• Formulation C23H43N3O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O.CC(C)(C)N
  Pathways:Endocrinology/Hormones; Immunology/Inflammation
  Receptor:MRP1; ACE
  Boling pt:537.4C?
  Melting pt:126-128C
  Solubility:Ethanol: 88 mg/mL (199.27 mM); Water: 88 mg/mL (199.27 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Ceconi C, et al. Eur J Pharmacol, 2007, 577(1-3), 1-6.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting